Company	:	20/20 GeneSystems, Inc.
Corporate Address	:	15810 Gaither Road, Suite 235, Gaithersburg, MD 20877
Offering Minimum	:	$9,995.40
Offering Maximum	:	$4,999,995.00
Minimum Investment Amount (per investor)	:	$500.00

Terms

Offering Type	:	Convertible Promissory Notes
Type of Equity Converted Into	:	Common Stock
Conversion Trigger	:	$100,000.00
Maturity Date	:	February 28, 2025
Valuation Cap	:	$58,400,000.00
Discount Rate	:	10.0%
Annual Interest Rate	:	6.0%

What is a Convertible Note?

A convertible note offers you the right to receive Common Stock in 20/20 GeneSystems, Inc.. The amount of Common Stock you will receive in the future will be determined at the next equity round in which the Company raises at least $100,000.00 in a qualified equity financing. The highest conversion price per security is set based on a $58,400,000.00 Valuation Cap or if less, then you will receive a 10.0% discount on the price the new investors are paying. You also receive 6.0% interest per year added to your investment. When the maturity date is reached, if the note has not converted then you are entitled to receive Common Stock equal to your investment and interest back at a price per security determined by dividing the Valuation Cap by the aggregate number of outstanding equity securities of the Company as of immediately prior (on a fully diluted basis).

Investment Incentives and Bonuses*

Time-Based:

Invest within the first 2 weeks and receive a 25% increase in the annual interest rate on Convertible Promissory Notes in this Offering, where by the interest rate will increase from 6% to 7.5%.

Amount-Based:

Tier 1 | $500+

Receive 1/3 off all 20/20 lab tests for 12 months. (Only if available in your country)

Tier 2 | $1,000+

Receive 1/2 off all 20/20 lab tests for 12 months. (Only if available in your country)

Tier 3 | $2,500+

Receive 1/2 off all 20/20 lab tests for 18 months. (Only if available in your country)

Tier 4 | $5,000+

Receive 1/2 off all 20/20 lab tests for 24 months. (Only if available in your country)

Tier 5 | $10,000+

Receive 1/2 off all 20/20 lab tests for life. (Only if available in your country)

*All perks occur when the offering is completed.

Audience-Based Perk

Loyalty Bonus | 50% bonus on interest

Previous 20/20 GeneSystems investors are eligible for an additional bonus on interest.

The 10% StartEngine Owners' Bonus

20/20 GeneSystems, Inc. will offer a 10% additional bonus for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.

Eligible StartEngine shareholders will receive a 10% increase in the annual interest rate on Convertible Promissory Notes in this Offering. This means your annual interest rate will be 6.6% instead of 6%.

This 10% Bonus is only valid during the investors' eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the Company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the Offering become available if prior investments are canceled or fail.

Investors will only receive a single bonus, which will be the highest bonus rate they are eligible for.

Lab-Based Diagnostic Testing Powered by AI and Real-World Data